Skip to main content

Table 1 Results of FoundationOne® companion diagnostic (F1CDx) assay

From: A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations

Biomarker findings

Genomic findings

MSI

Cannot be determined

PTEN

R233fs*10, splice site 480_492 + 2delCAGAGACAAAAAGGT

TMB

3Muts/Mb

RB1

Loss

  

TP53

R249G

  1. MSI, microsatellite instability; TMB, tumor mutational burden